サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1371951

感染管理市場の2030年までの予測：製品・サービス別、エンドユーザー別、地域別の世界分析

Infection Control Market Forecasts to 2030 - Global Analysis By Product & Service, By End User and By Geography
出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
感染管理市場の2030年までの予測：製品・サービス別、エンドユーザー別、地域別の世界分析
出版日: 2023年10月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界の感染管理市場は2023年に2,379億6,000万米ドルを占め、予測期間中にCAGR8.7%で成長し、2030年までに4,267億米ドルに達すると予測されています。

感染管理とは、細菌、ウイルス、真菌、寄生虫などの感染因子の拡散を防ぐことを目的とした一連の実践と対策を指し、ヘルスケア環境、地域環境、または感染伝播が起こり得るその他の状況において行われます。感染管理の主な目的は、個人を感染症から守り、人から人への感染拡大を防ぐことです。

WHOが発表した統計によると、急性呼吸器疾患（ARDs）は世界的に死亡率の高い主な原因の一つです。ARDsが原因で毎年約400万人が死亡しています。

院内感染（HAI）の増加

毎年、安全でない不十分な医療によって、何百万人もの患者が負傷または死亡しています。ヘルスケアに関連する数多くの医療処置やリスクが、不適切なケアによる危害の負担を著しく増大させています。世界保健機関（WHO）によると、安全でない外科処置による合併症は、患者の最大25％に影響を及ぼす可能性があります。高所得国および中低所得国の病院では、患者100人のうち7～10人がヘルスケア関連感染に苦しんでいます。また、米国疾病管理センター（CDC）は、HAIは170万人の感染に加え、年間99,000人の死亡の原因になっていると考えられると指摘しています。病院感染症は増加しており、これが感染管理製品への需要を煽り、市場拡大を加速させています。

化学消毒剤の悪影響

現在市販されている化学消毒剤の大半には毒性があります。消毒薬の誤用は、消毒薬にさらされた患者や環境を危険にさらす可能性があります。これらの消毒剤を殺虫剤に分類している環境保護庁（EPA）は、米国内で販売されるすべての消毒剤の登録を義務付けています。さらに、メーカーは現在、pH中性の第4級、ブチルフリー、過酸化水素をベースとした消毒剤など、よりクリーンで環境にやさしく、人の目へのダメージが少ない消毒剤の開発を迫られています。こうした要因が市場拡大を阻害しています。

新興市場での拡大

感染管理市場は、未開拓の機会、ヘルスケア部門のインフラ整備、製薬・医療機器企業の増加、感染管理製品に対する消費者需要の高まりによって拡大すると予測されます。新興国では、より洗練された製造システムに対する需要の高まりや、ヘルスケア・インフラのアップグレードに向けた政府の大規模な投資の結果、ヘルスケア・セクターが拡大しています。アジア諸国では、豊富な資源を背景に、医薬品研究や医療機器産業が成長しています。これらすべての要素を組み合わせることで、予測期間中に市場拡大のさまざまな機会がもたらされると予想されます。

ヘルスケア予算の制約とコンプライアンスの課題

ヘルスケア予算の制約やコスト重視の慣行は、高度な感染管理技術への投資を制限する可能性があります。市場の飽和とサプライヤー間の激しい競争は、価格に下落圧力をかけ、収益性に影響を与える可能性があります。さらに、さまざまな地域における規制の変更やコンプライアンス上の課題も脅威となり、企業は複雑な基準を乗り越える必要があるため、市場の成長はさらに抑制されます。

COVID-19の影響：

COVID-19の大流行は、世界の感染管理の実践に大きな影響を与えました。厳格な感染管理対策の重要性に対する認識が高まり、個人用保護具（PPE）、衛生用品、ヘルスケア用消毒剤の需要増につながっています。病院やヘルスケア施設は、病気の感染を防ぐためにより厳格なプロトコルを導入しています。さらに、パンデミックは新しい感染管理技術や戦略の開発と採用を加速させました。このパンデミックは、ヘルスケアや公共空間における感染管理への強固な備えと投資の必要性を改めて認識させるものであり、この期間中に進化する課題に対応するため、業界をさらに再形成しています。

予測期間中、病院セグメントが最大となる見込み

病院分野は市場貢献度が最も高く、予測期間中最大の市場シェアを占めると予想されます。病院には、訓練を受けた医療従事者、看護要員、専門機器を備えたヘルスケア施設があります。高いレベルの感染予防を確保するための政府のイニシアチブの増加、最先端の感染管理技術を備えた病院の増加、病院で行われる外科手術の増加、一人暮らしの高齢者の増加などが、このセグメントの拡大に寄与しています。

滅菌製品・サービス分野は予測期間中に最も高いCAGRが見込まれる

予測期間中、滅菌製品・サービス分野のCAGRが最も高くなると予測されます。感染症が病院やその他のヘルスケア施設全体に広がるのを防ぐには、滅菌が極めて重要です。世界保健機関（WHO）によれば、感染症は毎年1,700万人の命を奪っており、過去20年間に少なくとも30種類の新感染症が発生したと推定されています。予測期間中、手術率の上昇、感染症の蔓延、ヘルスケア分野の拡大が市場拡大に拍車をかけると予想されます。

最大シェアの地域：

予測期間中、北米は感染管理市場における主導権を維持すると予測されます。市場開拓に影響を与える重要な要因としては、同地域における大手市場プレイヤーの存在、整備されたヘルスケアインフラ、感染管理技術の普及などが挙げられます。同地域のシェアが大きいのは、主要市場企業が製品ポートフォリオと感染管理能力を拡大するために採用した戦略的提携の数が一貫して多いためと考えられます。さらに、この地域全体にプレゼンスを拡大しようとする既存企業の取り組みが活発化していることも、北米の圧倒的な市場シェアの要因となっています。

CAGRが最も高い地域：

アジア太平洋地域は、アウトソーシング企業の存在感の高まり、医療支出の増加、この地域全体のヘルスケア基準とインフラのかつてない進化により、予測期間を通じて最も高いCAGRを示すと予想されます。感染管理基準の改善に注力するさまざまな任意団体や政府機関の存在も、アジア太平洋地域の成長に寄与する重要な要因の1つです。さらに、新興経済諸国の既存市場企業がアジア太平洋地域の企業にアウトソーシングする傾向が強まっていることも、市場の成長を促す重要な要因となっています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場企業の包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の競合関係

第5章 世界の感染管理市場：製品・サービス別

  • 滅菌製品とサービス
    • 滅菌装置
      • 加熱殺菌装置
      • 乾熱滅菌器
      • 湿熱滅菌器
      • 低温殺菌
      • エチレンオキサイド滅菌（ETO）
      • ホルムアルデヒド滅菌
      • 過酸化水素滅菌
      • その他の低温殺菌
      • 濾過滅菌
      • 放射線滅菌
      • その他の設備
    • 受託滅菌サービス
      • 電子ビーム滅菌サービス
      • ETO滅菌サービス
      • ガンマ線滅菌サービス
      • 蒸気滅菌サービス
      • その他の滅菌サービス
    • 消耗品と付属品
      • 滅菌インジケーター
      • 生物学的指標
      • 化学インジケーター
      • 梱包用付属品
  • 洗浄および消毒製品
    • 消毒剤
      • 製品タイプ
      • 手指消毒剤
      • 器具消毒剤
      • 皮膚消毒剤
      • 表面消毒剤
      • 配合
      • 消毒スプレー
      • 消毒用ワイプ
      • 液体消毒剤
      • 環境保護庁（EPA）の分類
      • 高レベルの消毒剤
      • 中級消毒剤
      • 低レベル消毒剤
    • 洗浄および消毒装置
      • フラッシャー消毒器
      • 超音波洗浄器
      • 紫外線消毒器
      • ウォッシャーディスインフェクター
      • その他の洗浄および消毒機器
    • 消毒および洗浄アクセサリ
    • 潤滑剤および洗浄液
  • 保護バリア
    • 医療用不織布
      • フェイスマスク
      • 手術用ドレープ
      • 手術用ガウン
    • カバーとクロージャ
    • 手袋
    • ゴーグル
  • 内視鏡再処理製品
    • 内視鏡再処理消耗品
    • 内視鏡再処理装置
      • 自動内視鏡再処理装置
      • 内視鏡追跡システム
    • その他の内視鏡再処理製品
  • その他の感染管理製品

第6章 世界の感染管理市場：エンドユーザー別

  • 病院
  • クリニック
  • 食品業界
  • 研究室
  • 医療機器企業
  • 製薬会社
  • その他のエンドユーザー

第7章 世界の感染管理市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第8章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第9章 企業プロファイル

  • 3M Company
  • Advanced Sterilization Products
  • Belimed Ag.
  • Cantel Medical Corporation
  • Ecolab Inc.
  • Fortive Corporation（Advanced Sterilization Products）.
  • Genitge Ab.
  • Matachana Group.
  • Miele Group.（Steelco）
  • MMM Group
  • Sotera Health Inc.
  • Steris PLC
図表

List of Tables

  • Table 1 Global Infection Control Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Infection Control Market Outlook, By Product & Service (2021-2030) ($MN)
  • Table 3 Global Infection Control Market Outlook, By Sterilization Products and Services (2021-2030) ($MN)
  • Table 4 Global Infection Control Market Outlook, By Sterilization Equipment (2021-2030) ($MN)
  • Table 5 Global Infection Control Market Outlook, By Heat Sterilization Equipment (2021-2030) ($MN)
  • Table 6 Global Infection Control Market Outlook, By Low-Temperature Sterilization (2021-2030) ($MN)
  • Table 7 Global Infection Control Market Outlook, By Filtration Sterilization (2021-2030) ($MN)
  • Table 8 Global Infection Control Market Outlook, By Radiation Sterilization (2021-2030) ($MN)
  • Table 9 Global Infection Control Market Outlook, By Other Equipments (2021-2030) ($MN)
  • Table 10 Global Infection Control Market Outlook, By Contract Sterilization Services (2021-2030) ($MN)
  • Table 11 Global Infection Control Market Outlook, By E-Beam Sterilization Services (2021-2030) ($MN)
  • Table 12 Global Infection Control Market Outlook, By ETO Sterilization Services (2021-2030) ($MN)
  • Table 13 Global Infection Control Market Outlook, By Gamma Sterilization Services (2021-2030) ($MN)
  • Table 14 Global Infection Control Market Outlook, By Steam Sterilization Services (2021-2030) ($MN)
  • Table 15 Global Infection Control Market Outlook, By Other Sterilization Services (2021-2030) ($MN)
  • Table 16 Global Infection Control Market Outlook, By Consumables and Accessories (2021-2030) ($MN)
  • Table 17 Global Infection Control Market Outlook, By Sterilization Indicators (2021-2030) ($MN)
  • Table 18 Global Infection Control Market Outlook, By Packaging Accessories (2021-2030) ($MN)
  • Table 19 Global Infection Control Market Outlook, By Cleaning and Disinfection Products (2021-2030) ($MN)
  • Table 20 Global Infection Control Market Outlook, By Disinfectants (2021-2030) ($MN)
  • Table 21 Global Infection Control Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 22 Global Infection Control Market Outlook, By Formulation (2021-2030) ($MN)
  • Table 23 Global Infection Control Market Outlook, By Environmental Protection Agency (EPA) Classification (2021-2030) ($MN)
  • Table 24 Global Infection Control Market Outlook, By Cleaning and Disinfection Equipment (2021-2030) ($MN)
  • Table 25 Global Infection Control Market Outlook, By Flusher Disinfectors (2021-2030) ($MN)
  • Table 26 Global Infection Control Market Outlook, By Ultrasonic Cleaners (2021-2030) ($MN)
  • Table 27 Global Infection Control Market Outlook, By UV-Ray Disinfectors (2021-2030) ($MN)
  • Table 28 Global Infection Control Market Outlook, By Washer Disinfectors (2021-2030) ($MN)
  • Table 29 Global Infection Control Market Outlook, By Other Cleaning and Disinfection Equipments (2021-2030) ($MN)
  • Table 30 Global Infection Control Market Outlook, By Disinfection and Cleaning Accessories (2021-2030) ($MN)
  • Table 31 Global Infection Control Market Outlook, By Lubricants and Cleaning Solutions (2021-2030) ($MN)
  • Table 32 Global Infection Control Market Outlook, By Protective Barriers (2021-2030) ($MN)
  • Table 33 Global Infection Control Market Outlook, By Medical Nonwovens (2021-2030) ($MN)
  • Table 34 Global Infection Control Market Outlook, By Face Masks (2021-2030) ($MN)
  • Table 35 Global Infection Control Market Outlook, By Surgical Drapes (2021-2030) ($MN)
  • Table 36 Global Infection Control Market Outlook, By Surgical Gowns (2021-2030) ($MN)
  • Table 37 Global Infection Control Market Outlook, By Covers and Closures (2021-2030) ($MN)
  • Table 38 Global Infection Control Market Outlook, By Gloves (2021-2030) ($MN)
  • Table 39 Global Infection Control Market Outlook, By Goggles (2021-2030) ($MN)
  • Table 40 Global Infection Control Market Outlook, By Endoscope Reprocessing Products (2021-2030) ($MN)
  • Table 41 Global Infection Control Market Outlook, By Endoscope Reprocessing Consumables (2021-2030) ($MN)
  • Table 42 Global Infection Control Market Outlook, By Endoscope Reprocessing Equipment (2021-2030) ($MN)
  • Table 43 Global Infection Control Market Outlook, By Automated Endoscope Reprocessors (2021-2030) ($MN)
  • Table 44 Global Infection Control Market Outlook, By Endoscope Tracking Systems (2021-2030) ($MN)
  • Table 45 Global Infection Control Market Outlook, By Other Endoscope Reprocessing Products (2021-2030) ($MN)
  • Table 46 Global Infection Control Market Outlook, By Other Infection Control Products (2021-2030) ($MN)
  • Table 47 Global Infection Control Market Outlook, By End User (2021-2030) ($MN)
  • Table 48 Global Infection Control Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 49 Global Infection Control Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 50 Global Infection Control Market Outlook, By Food Industry (2021-2030) ($MN)
  • Table 51 Global Infection Control Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 52 Global Infection Control Market Outlook, By Medical Device Companies (2021-2030) ($MN)
  • Table 53 Global Infection Control Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 54 Global Infection Control Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次
Product Code: SMRC24008

According to Stratistics MRC, the Global Infection Control Market is accounted for $237.96 billion in 2023 and is expected to reach $426.70 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Infection control refers to a set of practices and measures aimed at preventing the spread of infectious agents, such as bacteria, viruses, fungi, and parasites, within healthcare settings, community environments, or other contexts where the transmission of infections can occur. The primary goals of infection control are to protect individuals from acquiring infections and to prevent the spread of infections from one person to another.

According to the statistics published by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Approximately 4.0 million deaths occur every year due to ARDs.

Market Dynamics:

Driver:

Rising prevalence of hospital-acquired infections (HAIs)

Every year, unsafe and inadequate medical care results in the injuries or deaths of millions of patients. Numerous medical procedures and risks associated with healthcare significantly increase the burden of harm from inadequate care. According to the World Health Organization, complications from unsafe surgical procedures can affect up to 25% of patients. 7 to 10 out of every 100 patients in hospitals in high-income and low- and middle-income countries suffer from healthcare-associated infections. The Centers for Disease Control (CDC) also note that HAIs are thought to be responsible for 99,000 fatalities annually in addition to 1.7 million infections. Hospital infections are increasing, which has fueled demand for infection control products and accelerated market expansion.

Restraint:

Negatively effects of chemical disinfectants

The majority of chemical disinfectants currently available on the market have toxic properties. Misuse of disinfectants can put patients exposed to them and the environment in danger. The Environmental Protection Agency (EPA), which classifies these disinfection products as pesticides, requires registration for all disinfectants sold in the US. Moreover, manufacturers are currently under pressure to develop cleaner, more environmentally friendly disinfectants that are less damaging to people's eyes, like pH-neutral quaternary, butyl-free, and disinfectants based on hydrogen peroxide. Such factors impede market expansion.

Opportunity:

Growing expansion in emerging markets

The market for infection control is predicted to grow as a result of untapped opportunities, improved infrastructure for the healthcare sector, an increase in the number of pharmaceutical and medical device companies, and rising consumer demand for infection control products. The healthcare sector is expanding in emerging economies as a result of the rise in demand for more sophisticated manufacturing systems and significant government investments to upgrade healthcare infrastructure. Asian countries have experienced growth in the pharmaceutical research and medical device industries as a result of the abundance of resources available. Combining all these elements is anticipated to present a variety of opportunities for market expansion during the forecast period.

Threat:

Healthcare budget constraints and compliance challenges

Healthcare budget constraints and cost-conscious practices may limit investments in advanced infection control technologies. Market saturation and intense competition among suppliers could exert downward pressure on prices, potentially impacting profitability. Additionally, regulatory changes and compliance challenges in different regions also pose a threat, requiring companies to navigate complex standards, which further restrains market growth.

COVID-19 Impact:

The COVID-19 pandemic has profoundly impacted infection control practices worldwide. It has heightened awareness about the importance of stringent infection control measures, leading to increased demand for personal protective equipment (PPE), sanitation products, and healthcare disinfectants. Hospitals and healthcare facilities have implemented more rigorous protocols to prevent disease transmission. Additionally, the pandemic has accelerated the development and adoption of novel infection control technologies and strategies. It serves as a stark reminder of the need for robust preparedness and investment in infection control in healthcare and public spaces, further reshaping the industry to meet evolving challenges during this period.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment contributes the most to the market and is anticipated to have the largest market share during the forecast period. Hospitals contain healthcare facilities with trained medical personnel, nursing personnel, and specialized equipment. Increased government initiatives to ensure high levels of infection prevention, an increase in hospitals with cutting-edge infection control techniques, an increase in the number of surgical procedures carried out in hospitals, and an increase in the number of elderly people living alone are all factors contributing to the segment's expansion.

The sterilization products and services segment is expected to have the highest CAGR during the forecast period

During the anticipated timeframe, the segment for sterilization products and services is predicted to have the highest CAGR. Antibiotics might not be able to stop such a widespread attack, so sterilization is crucial to preventing infectious diseases from spreading throughout hospitals or other healthcare facilities. Infectious diseases claim the lives of 17 million people each year, according to the World Health Organization (WHO), which estimates that at least 30 new diseases have emerged in the last 20 years. Over the course of the forecast period, it is also anticipated that rising surgical rates, an increase in the prevalence of infectious diseases, and expansion in the healthcare sector will spur market expansion.

Region with largest share:

During the forecast period, North America is anticipated to maintain its leadership in the infection control market. Some important factors influencing market growth include the presence of major market players in the region, a well-developed healthcare infrastructure, and the widespread use of infection control technologies. The larger share seized by this region is thought to be due to a consistent number of strategic collaborations adopted by key market players to expand their product portfolio and infection control capabilities. Additionally, the established businesses' increased efforts to expand their presence throughout this region are to blame for North America's dominant market share.

Region with highest CAGR:

Asia Pacific region is expected to exhibit the highest CAGR throughout the forecast period owing to the growing presence of outsourcing organizations, growing healthcare expenditure, and the unprecedented evolution of healthcare standards and infrastructure across this region. The presence of various voluntary and government organizations focused on improving infection control standards is also one of the significant factors contributing to the growth of the Asia-Pacific region. Additionally, the increasing trend of outsourcing by established market players in developed economies to companies in the Asia-Pacific region also serves as a key growth-impelling factor for the market.

Key players in the market:

Some of the key players in Infection Control Market include: Ecolab Inc., Fortive Corporation (Advanced Sterilization Products), Genitge Ab, Matachana Group, Miele Group. (Steelco), MMM Group, Sotera Health Inc and Steris PLC.

Key Developments:

In September 2023, 3M reported that both the split-off exchange offer for 3M common stock and the closure of the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary owning the food safety business, with a subsidiary of Neogen Corporation had been completed ("Neogen").

In June 2023, Social care nurses in Scotland can now access the latest infection prevention and control (IPC) guidance in their pocket thanks to a new app launched this week. It was developed in partnership between the Scottish Social Services Council (SSSC), NHS Education for Scotland (NES) and the Digital Health & Care Innovation Centre (DHI).

In May 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. Getinge has paid approximately SEK 1,330 M (USD 120 M) in cash on closing, on a cash and debt free basis for 100 % of the shares. In addition, a maximum earn out of approximately SEK 1,880 M (USD 170 M) can be paid out during 2024 - 2026 if agreed net revenue performance milestones are achieved in 2023 - 2025.

Product & Services Covered:

  • Sterilization Products and Services
  • Cleaning and Disinfection Products
  • Protective Barriers
  • Endoscope Reprocessing Products
  • Other Infection Control Products

End Users Covered:

  • Hospitals
  • Clinics
  • Food Industry
  • Laboratories
  • Medical Device Companies
  • Pharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infection Control Market, By Product & Service

  • 5.1 Introduction
  • 5.2 Sterilization Products and Services
    • 5.2.1 Sterilization Equipment
      • 5.2.1.1 Heat Sterilization Equipment
      • 5.2.1.1.1 Dry Heat Sterilizers
      • 5.2.1.1.2 Moist Heat Sterilizers
      • 5.2.1.2 Low-Temperature Sterilization
      • 5.2.1.2.1 Ethylene Oxide Sterilization (ETO)
      • 5.2.1.2.2 Formaldehyde Sterilization
      • 5.2.1.2.3 Hydrogen Peroxide Sterilization
      • 5.2.1.2.4 Other Low-Temperature Sterilization
      • 5.2.1.3 Filtration Sterilization
      • 5.2.1.4 Radiation Sterilization
      • 5.2.1.5 Other Equipments
    • 5.2.2 Contract Sterilization Services
      • 5.2.2.1 E-Beam Sterilization Services
      • 5.2.2.2 ETO Sterilization Services
      • 5.2.2.3 Gamma Sterilization Services
      • 5.2.2.4 Steam Sterilization Services
      • 5.2.2.5 Other Sterilization Services
    • 5.2.3 Consumables and Accessories
      • 5.2.3.1 Sterilization Indicators
      • 5.2.3.1.1 Biological Indicators
      • 5.2.3.1.2 Chemical Indicators
      • 5.2.3.2 Packaging Accessories
  • 5.3 Cleaning and Disinfection Products
    • 5.3.1 Disinfectants
      • 5.3.1.1 Product Type
      • 5.3.1.1.1 Hand Disinfectants
      • 5.3.1.1.2 Instrument Disinfectants
      • 5.3.1.1.3 Skin Disinfectants
      • 5.3.1.1.4 Surface Disinfectants
      • 5.3.1.2 Formulation
      • 5.3.1.1 Disinfectant Sprays
      • 5.3.1.2 Disinfectant Wipes
      • 5.3.1.3 Liquid Disinfectants
      • 5.3.1.3 Environmental Protection Agency (EPA) Classification
      • 5.3.1.3.1 High-Level Disinfectants
      • 5.3.1.3.2 Intermediate-Level Disinfectants
      • 5.3.1.3.3 Low-Level Disinfectants
    • 5.3.2 Cleaning and Disinfection Equipment
      • 5.3.2.1 Flusher Disinfectors
      • 5.3.2.2 Ultrasonic Cleaners
      • 5.3.2.3 UV-Ray Disinfectors
      • 5.3.2.4 Washer Disinfectors
      • 5.3.2.5 Other Cleaning and Disinfection Equipments
    • 5.3.3 Disinfection and Cleaning Accessories
    • 5.3.4 Lubricants and Cleaning Solutions
  • 5.4 Protective Barriers
    • 5.4.1 Medical Nonwovens
      • 5.4.1.1 Face Masks
      • 5.4.1.2 Surgical Drapes
      • 5.4.1.3 Surgical Gowns
    • 5.4.2 Covers and Closures
    • 5.4.3 Gloves
    • 5.4.4 Goggles
  • 5.5 Endoscope Reprocessing Products
    • 5.5.1 Endoscope Reprocessing Consumables
    • 5.5.2 Endoscope Reprocessing Equipment
      • 5.5.2.1 Automated Endoscope Reprocessors
      • 5.5.2.2 Endoscope Tracking Systems
    • 5.5.3 Other Endoscope Reprocessing Products
  • 5.6 Other Infection Control Products

6 Global Infection Control Market, By End User

  • 6.1 Introduction
  • 6.2 Hospitals
  • 6.3 Clinics
  • 6.4 Food Industry
  • 6.5 Laboratories
  • 6.6 Medical Device Companies
  • 6.7 Pharmaceutical Companies
  • 6.8 Other End Users

7 Global Infection Control Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 3M Company
  • 9.2 Advanced Sterilization Products
  • 9.3 Belimed Ag.
  • 9.4 Cantel Medical Corporation
  • 9.5 Ecolab Inc.
  • 9.6 Fortive Corporation (Advanced Sterilization Products).
  • 9.7 Genitge Ab.
  • 9.8 Matachana Group.
  • 9.9 Miele Group. (Steelco)
  • 9.10 MMM Group
  • 9.11 Sotera Health Inc.
  • 9.12 Steris PLC